Nov 16, 2022
"Conferences are where you go to see the interesting young companies coming into the space. And so we all have to attend. It's probably odd for a physician to see somebody from Wall Street attending a medical meeting, but we all do it."
Imagine casually referencing how your company manages over $100 billion in assets. As the head of the biotechnology equity research team for William Blair & Company, Tim Lugo does just that in this interview with Dr. Grant Stevens. With all manner of aesthetic investments under his purview, Tim offers a uniquely embracive perspective on the aesthetic industry in this episode of The Technology of Beauty.